Skip to main content
Livermore
Livermore
ZHEN

Alps Advisors Inc

SEC CIK
0001376113
Latest filing
Jul 29, 2026

VNDA holding history

Vanda Pharmaceuticals Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VNDA overviewAll 13F holders of VNDAFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of VNDA by Alps Advisors Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−48,116−100.0%Sold outHolders
Q1 202648,116$332.5K<0.1%−406−0.8%ReducedHolders
Q4 202548,522$428.0K<0.1%+20,597+73.8%AddedHolders
Q3 202527,925$139.3K<0.1%−3,834−12.1%ReducedHolders
Q2 202531,759$149.9K<0.1%−10,234−24.4%ReducedHolders
Q1 202541,993$192.7K<0.1%−5,156−10.9%ReducedHolders
Q4 202447,149$225.8K<0.1%+3,113+7.1%AddedHolders
Q3 202444,036$206.5K<0.1%−1,360−3.0%ReducedHolders
Q2 202445,396$256.5K<0.1%+4,812+11.9%AddedHolders
Q1 202440,584$166.8K<0.1%+152+0.4%AddedHolders
Q4 202340,432$170.6K<0.1%−1,965−4.6%ReducedHolders
Q3 202342,397$183.2K<0.1%+173+0.4%AddedHolders
Q2 202342,224$278.3K<0.1%+4,814+12.9%AddedHolders
Q1 202337,410$254.0K<0.1%−1,073−2.8%ReducedHolders
Q4 202238,483$284.4K<0.1%+7,675+24.9%AddedHolders
Q3 202230,808$304.0K<0.1%−2,704−8.1%ReducedHolders
Q2 202233,512$365.0K<0.1%−23,943−41.7%ReducedHolders
Q1 202257,455$650.0K<0.1%−7,014−10.9%ReducedHolders
Q4 202164,469$1.01M<0.1%−3,724−5.5%ReducedHolders
Q3 202168,193$1.17M<0.1%−4,992−6.8%ReducedHolders
Q2 202173,185$1.57M<0.1%−26,105−26.3%ReducedHolders
Q1 202199,290$1.49M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.